Search by Drug Name or NDC

    NDC 00002-8235-05 LYUMJEV 100 [iU]/mL Details

    LYUMJEV 100 [iU]/mL

    LYUMJEV is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00002-8235
    Product ID 0002-8235_6f84ba56-a2a5-440e-9d3f-334655934a53
    Associated GPIs
    GCN Sequence Number 085478
    GCN Sequence Number Description insulin lispro-aabc INSULN PEN 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 54973
    HICL Sequence Number 046616
    HICL Sequence Number Description INSULIN LISPRO-AABC
    Brand/Generic Brand
    Proprietary Name LYUMJEV
    Proprietary Name Suffix Tempo Pen
    Non-Proprietary Name Insulin lispro-aabc
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN LISPRO
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761109
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-8235-05 (00002823505)

    NDC Package Code 0002-8235-05
    Billing NDC 00002823505
    Package 5 SYRINGE in 1 CARTON (0002-8235-05) / 3 mL in 1 SYRINGE (0002-8235-01)
    Marketing Start Date 2022-09-29
    NDC Exclude Flag N
    Pricing Information N/A